133 related articles for article (PubMed ID: 8423936)
1. Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients.
Hnatowich DJ; Mardirossian G; Rusckowski M; Roy S; Bushe H; Griffin TW; Brill AB
Nucl Med Commun; 1993 Jan; 14(1):52-63. PubMed ID: 8423936
[TBL] [Abstract][Full Text] [Related]
2. The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.
Mardirossian G; Wu C; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 1992 Jul; 13(7):503-12. PubMed ID: 1495677
[TBL] [Abstract][Full Text] [Related]
3. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
[TBL] [Abstract][Full Text] [Related]
4. In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragments.
Kinne RW; Schemer K; Behr T; Sharkey RM; Palombokinne E; Emmrich F; Goldenberg DM; Wolf F; Becker W
Nucl Med Commun; 1999 Jan; 20(1):67-75. PubMed ID: 9949415
[TBL] [Abstract][Full Text] [Related]
5. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
Tibben JG; Massuger LF; Claessens RA; Schijf CP; Pak KY; Strijk SP; Kenemans P; Corstens FH
Nucl Med Commun; 1992 Dec; 13(12):885-93. PubMed ID: 1465272
[TBL] [Abstract][Full Text] [Related]
6. Imaging lung cancer by scintigraphy with Indium 111-labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5.
Buccheri G; Biggi A; Ferrigno D; D'Angeli B; Vassallo G; Leone A; Taviani M; Comino A
Cancer; 1992 Aug; 70(4):749-59. PubMed ID: 1643607
[TBL] [Abstract][Full Text] [Related]
7. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
Vuillez JP; Moro D; Brambilla E; Brichon PY; Ferretti G; Saccavini JC; Brambilla C
Eur J Cancer; 1994; 30A(8):1089-92. PubMed ID: 7654435
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoscintigraphy with 111In labelled monoclonal antibody fragments (F(ab')2 BW 431/31) against CEA: radiolabelling, antibody kinetics and distribution, findings in tumour and non-tumour patients.
Bares R; Fass J; Truong S; Buell U; Schumpelick V
Nucl Med Commun; 1989 Sep; 10(9):627-41. PubMed ID: 2616103
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
11. Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients.
Tibben JG; Thomas CM; Massuger LF; Segers MF; Schijf CP; Corstens FH; Boerman OC
Nucl Med Commun; 1995 Oct; 16(10):853-9. PubMed ID: 8570116
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG
Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
[TBL] [Abstract][Full Text] [Related]
13. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations.
Macmillan CH; Perkins AC; Wastie ML; Leach IH; Morgan DA
Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288
[TBL] [Abstract][Full Text] [Related]
14. 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.
Peters AM; Roddie ME; Danpure HJ; Osman S; Zacharopoulos GP; George P; Stuttle AW; Lavender JP
Nucl Med Commun; 1988 Jun; 9(6):449-63. PubMed ID: 3412733
[TBL] [Abstract][Full Text] [Related]
15. Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments.
O'Byrne KJ; Hamilton D; Robinson I; Sweeney E; Freyne PJ; Cullen MJ
Nucl Med Commun; 1992 Mar; 13(3):142-8. PubMed ID: 1557212
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
[TBL] [Abstract][Full Text] [Related]
17. Structural modifications of monoclonal antibodies following direct versus indirect labelling with 99Tcm: does fragmentation really occur?
Behr T; Becker W; Hannappel E; Wolf F
Nucl Med Commun; 1994 Nov; 15(11):865-70. PubMed ID: 7870392
[TBL] [Abstract][Full Text] [Related]
18. Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate.
Petrov AD; Narula J; Nakazawa A; Pak KY; Khaw BA
Nucl Med Commun; 1997 Mar; 18(3):241-51. PubMed ID: 9106778
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
Casey JL; King DJ; Chaplin LC; Haines AM; Pedley RB; Mountain A; Yarranton GT; Begent RH
Br J Cancer; 1996 Nov; 74(9):1397-405. PubMed ID: 8912535
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous administration of 99Tcm-HMPAO-labelled autologous leukocytes and 111In-labelled non-specific polyclonal human immunoglobulin G in bone and joint infections.
de Lima Ramos PA; Martin-Comin J; Bajén MT; Roca M; Ricart Y; Castell M; Mora J; Puchal R; Ramos M
Nucl Med Commun; 1996 Sep; 17(9):749-57. PubMed ID: 8895902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
